1Albright, FA, Reifenstein, ED.The parathyroid glands and metabolic bone disease. Baltimore: Williams & Wilkins, 1948.
2Riggs, BL, Melton, LJ.Osteoporosis, etiology, diagnosis and management. New York: Raven Press, 1988.
3Riggs, BL, Melton, LJ.The prevention and therapy of osteoporosis. N Engl J Med 1992; 327: 620–27.
4Cooper, C, Atkinson, EJ, O'Fallon, WM, Melton, LJ.The incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 1992; 7: 221–27.
5Cooper, C, Shah, S, Hand, DJ, Compston, J, Davie, M.Screening for osteoporosis using individual risk factors. Osteoporosis Int 1991; 2: 48–53.
6Cooper, C.Vertebral fractures. How large is the silent epidemic? Br Med J 1992; 304: 793–94.
7Resnick, NM, Greenspan, SL.‘Senile’ osteoporosis reconsidered. JAMA 1989; 261: 1025–29.
8Van, Os C.Transcellular calcium transport in intestinal and renal epithelial cells. Biochem Biophys Acta 1987; 906: 195–22.
9Bronner, F. Calcium absorption. In: Johnson, LR ed. Physiology of the gastrointestinal tract, second edition. New York: Raven Press, 1987: 1419–34.
10Heersche, JNM. Bone cells and bone turnover; the basis for pathogenesis. In: Tarn, CS, Heersche, JNM, Murray, TM eds. Metabolic bone disease: cellular and tissue mechanism. Boca Raton: CRC Press, 1989: 1–19.
11Hodgson, SF.Corticosteroid-induced osteoporosis. Endocrinol Metab Clin North Am 1990; 19: 95–112.
12Duursma, SA, Slootweg, MC, Bijlsma, JWJ. How does oestrogen prevent postmenopausal osteoporosis? In: Bergener, M, Ermini, M, Stāhelin, HB eds. Crossroads in aging. Academic Press, 1988: 169–80.
13Reginster, TY, Deroisy, R, Albert, A.Relationship between whole plasma calcitonin levels, calcitonin secretion capacity, and plasma levels of estron in healthy women and postmenopausal osteoporotics. J Clin Invest 1989; 83: 1073–77.
14Tørring, O, Bucht, E, Sjöberg, HE.The influence of sex steroid hormones on plasma calcitonin response to the calcium clamp in normal subjects. J Bone Miner Res 1987; 2: 407–11.
15Feyen, JHM, Raisz, LG.Prostaglandin production by calvaria from sham operated rats: effect of 17 '-estradiol in vivo. Endocrinology 1987; 121: 819–21.
16Duursma, SA, Jaszmann, LBJ, De Raadt, ME, Van Rhijn, HJM, Wit, JM, Raymakers, JA. Changes in insulin-like growth factor-I and growth hormone and prevention of bone loss during oestrogen replacement therapy. Growth Regulation 1992 (in press).
17McCarthy, TL, Centrella, M, Canalis, E.Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 1989; 124: 301–309.
18Scheven, BAA, Hamilton, NJ.Stimulation of macrophage growth and induction of multinucleated cell formation in rat bone marrow cultures by insulin-like growth factor. Biochem Biophys Res Commun 1992; 174: 647–53.
19Slootweg, MC, Hermann-Erlee, MPM, Van der Meer, JM, Duursma, SA.Fetal mouse osteoblasts respond to physiological concentrations of growth hormone and produce insulin-like growth factors. Calcif Tissue Int 1987; 46 (suppl): OP11.
20Slootweg, MC, Otte, AP, Van Genesen, AP, Duursma, SA, Kuijer, W.Signal transduction of mouse osteoblast growth hormone receptor: independent of phosphoinositide breakdown and c-AMP. J Bone Miner Res 1989; 4 (suppl): S340.
21Scheven, BAA, Damen, CA, Hamilton, NJ, Verhaar, HJJ, Duursma, SA.Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro. Biochem Biol Res Commun 1992; 186: 54–60.
22Jilka, RL, Hangoc, G, Girasolr, G et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257: 89–91.
23Tobias, JH, Chambers, TJ.The effect of sex hormones on bone resorption by rat osteoclasts. Acta Endocrinol (Copenh) 1991; 124: 121–27.
24Mosekilde, L, Eriksen, EF, Charles, P.Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North 1990; 19: 35–64.
25Parisien, M, Silverberg, SJ, Shane, E, Dempster, DW, Bilezikian, JP.Bone disease in primary hyperthyroidism. Endocrinol Metab Clin North Am 1990; 19: 19–34.
26Baillie, SP, Davidson, CE, Johnson, FJ, Francis, RM.Pathogenesis of vertebral crush fractures in men. Age Ageing 1992; 21: 139–41.
27Jackson, JA, Riggs, MW, Spiekerman, AM.Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 1992; 304: 4–8.
28Rudman, D, Feller, AG, Cohn, L, Shetty, KR, Rudman, IW, Draper, MW.Effects of human growth hormone on body composition in elderly men. Horm Res 1991; 36: 73–81.
29Duursma, SA, Raymakers, JA. Osteoporosis and exercise. In: Hermans, GPH, Mosterd, WL eds. Sports, medicine and health. Amsterdam: Elsevier, 1990: 119–28.
30Blumenthal, JA, Emery, CF, Madden, DJ et al. Effects of exercise training on bone density in older men and women. J Am Geriatr Soc 1991; 39: 1065–70.
31McKenna, MJ.Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992; 93: 69–77.
32McMurthy, CT, Young, SE, Downs, RW, Adler, RA.Mild vitamin D deficiency and secondary hyperparathyroidism in nursing home patients receiving adequate dietary vitamin D. J Am Geriatr Soc 1992; 40: 343–47.
33Lips, P, Van Ginkel, FC, Jongen, MJ.Determinants of vitamin D status in patients with hip fracture and elderly control subjects. Am J Clin Nutr 1987; 46: 1005–10.
34Zetterberg, C, Mannius, S, Melstrom, D, Rundgren, A, Astrand, K.Osteoporosis and back pain in the elderly. A controlled epidemiologic and radiographic study. Spine 1990; 15: 783–86.
35Finsen, V.Osteoporosis and back pain among the elderly. Acta Med Scand 1988; 223: 443–49.
36Leidig, G, Minne, HW, Sauer, P, Wüster, C, Wüster, L, Lojen, M.A study of complaints and their relation to vertebral destruction in patients with osteoporosis. Bone Miner 1990; 8: 217–29.
37Christiansen, C, Riis, BJ, Rodbro, P.Prediction of rapid bone loss in postmenopausal women. Lancet 1987; i: 1105–1108.
38Melton, LJ, Kan, SH, Wahner, HW, O'Fallon, WM.Riggs, BL.Epidemiology of vertebral fractures in women. Am J Epidemiol 1989; 129: 1000–11.
39Ross, PD, Wasnich, RD, Vogel, JM.Detection of prefracture spinal osteoporosis using bone mineral absortiometry. J Bone Miner Res 1988; 3: 1–11.
40Eastell, R, Cedel, SL, Wahner, HW, Riggs, BL, Melton, LJ.Classification of vertebral fractures. J Bone Miner Res 1991; 6: 207–15.
41. Consensus development conference: prophylaxis and treatment of osteoporosis. Osteoporosis Int 1991; 1: 114–17.
42Dequeker, J, Geusens, P.Treatment of established osteoporosis and rehabilitation: current practice and possibilities. Maturitas 1990; 12: 1–36.
43Kanis, JA, Passmore, R.Calcium supplementation of the diet: not justified by present evidence. Br Med J 1989; 298: 205–208.
44Nordin, BEC, Heaney, RP.Calcium supplementation of the diet: justified by present evidence. Br Med J 1990; 300: 1056–60.
45Elders, PJM, Netelenbos, JC, Lips, P.Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Endocrinol Metab 1991; 73: 533–40.
46Lindsay, R, Thome, JF. Estrogen treatment with established postmenopausal osteoporosis. Obstet Gynecol 1990; 76: 290–95.
47Lufkin, EG, Wahner, HW, O'Fallon, WM, Hodgson, WF, Kotowicz, MA, Lane, AW.Treatment of osteoporosis by transdermal estrogen administration. Ann Intern Med 1992; 117: 1–9.
48Ott, SM.Estrogen therapy for osteoporosis. Even in the elderly. Ann Intern Med 1992; 117: 85–86.
49Need, AG, Horowitz, M, Walker, CJ, Chatterton, BE, Chapman, IC, Nordin, BEC.Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis. Bone 1987; 10: 3–6.
50Hassager, C, Riis, BJ, Podenphant, J, Christiansen, C.Nandrolone decanoate treatment of postmenopausal osteoporosis for two years and effects of withdrawal. Maturitas 1989; 11: 305–17.
51Johansen, JS, Hassager, C, Podenphant, J.Treatment of postmenopausal osteoporosis. Is anabolic steroid nandrolone decanoate a candidate? Bone Miner 1989; 6: 77–86.
52Lyritis, GP, Tsakalakos, N, Magiasis, B, Karachalios, B, Yiatzides, A, Tsekoura, M.Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double blind placebo controlled clinical study. Calcif Tissue Int 1991; 49: 369–72.
53Civitelli, R, Gonelli, S, Zacchei, F.Bone turn-over in postmenopausal osteoporosis: effect of calcitonin treatment. J Clin Invest 1988; 82: 1268–74.
54Reginster, JY, Dennis, D, Albert, A.1-year controlled randomization trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancel 1987; ii: 1481–83.
55Reginster, JY.Effect of calcitonin on bone mass and fracture rate. Am J Med 1991; 91: 19–22.
56Overgaard, K, Riis, BJ, Christiansen, C, Hansen, MA.Effect of calcitonin given intranasally on early postmenopausal bone loss. Br Med J 1989; 299: 477–79.
57Ringe, JD, Welzel, D.Salmon calcitonin in the therapy of corticoid-induced osteoporosis. Eur J Pharmacol 1987; 33: 35–39.
58Storm, T, Thamsborg, G, Steiniche, T, Genant, HK, Sørensen, OH.Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990; 322: 1265–71.
59Watts, NB, Harris, ST, Genant, HK, Wasnich, RD, Miller, PD, Jackson, RD. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990; 323: 73–79.
60Reid, IR, King, AR, Alexander, CJ, Ibbertson, HK. Prevention of steroid-induced osteoporosis with (3 amino-1-hydroxypropylidene)-1, 1-bisphosphonate (APD). Lancet 1988; i: 143–46.
61Lau, HW, Farley, JR, Baylink, DJ. Molecular mechanism of the mitogenic action of fluoride: inhibition of osteoblastic acid phosphatase-like phosphotyrosyl protein phosphatase activity. In: Christiansen, C, Johansen, JS, Riis, BJ eds. Osteoporosis 1987. Copenhagen: Osteopress ApS, 1987: 824–28.
62Kappelle, JW. Effects of 24,25 dihydroxycholecalciferol in healthy subjects and patients treated with fluoride for osteoporosis [Thesis]. Utrecht, 1991.
63Duursma, SA, Raymakers, JA, De Raadt, ME, Karsdorf, MJGH, Van Dijk, A, Glerum, J.Urinary fluoride excretion in responders and nonresponders after fluoride therapy in osteoporosis. J Bone Miner Res 1990; 5 (suppl 1): S43–47.
64Pak, CYC, Sakhaee, K, Zerwekh, JE, Parcel, C, Peterson, R, Johnson, K.Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone loss and inhibition of fractures. J Clin Endocrinol Metab 1990; 68: 150–59.
65Delmas, PD, Dupuis, J, Duboeuf, F, Chapuy, MC, Meunier, PJ.Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J Bone Miner Res 1990; 5 (suppl 1): S143–47.
66Riggs, BL, Hodgson, SF, O'Fallon, WF.Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990; 322: 802–809.
67Kleerekoper, M, Peterson, EL, Nelson, DA.A randomized trial of sodium fluoride as a treatment postmenopausal osteoporosis. Osteoporosis Int 1991; 1: 155–61.
68Mamelle, N, Meunier, PJ, Netter, P.Fluoride and vertebral fractures. Lancet 1990; i: 336–43.
69Canalis, E, Centrella, M, Burch, W, McCarthy, TL.Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone culture. J Clin Invest 1989; 83: 60–65.